首页> 外文期刊>American Journal of Infection Control >Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission
【24h】

Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission

机译:囊性纤维化患者的感染控制建议:微生物学,重要病原体和防止患者间传播的感染控制措施

获取原文
           

摘要

Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission updates, expands, and replaces the consensus statement, Microbiology and Infectious Disease in Cystic Fibrosis published in 1994. This consensus document presents background data and evidence-based recommendations for practices that are intended to decrease the risk of transmission of respiratory pathogens among CF patients from contaminated respiratory therapy equipment or the contaminated environment and thereby reduce the burden of respiratory illness. Included are recommendations applicable in the acute care hospital, ambulatory, home care, and selected non-healthcare settings. The target audience includes all healthcare workers who provide care to CF patients. Antimicrobial management is beyond the scope of this document.
机译:囊性纤维化患者的感染控制建议:微生物学,重要的病原体和感染控制措施,以防止患者之间向患者的传播,更新,扩展并替代了1994年发表的共识性声明《囊性纤维化的微生物学和传染性疾病》。该共识性文件提出了一些实践经验的背景数据和基于证据的建议,旨在降低受污染的呼吸治疗设备或受污染的环境在CF患者中传播呼吸道病原体的风险,从而减轻呼吸道疾病的负担。其中包括适用于急诊医院,非卧床,家庭护理和选定的非保健场所的建议。目标受众包括为CF患者提供护理的所有医护人员。抗菌管理不在本文件范围内。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号